Avalo Therapeutics (AVTX) P/E (2023 - 2026)
Avalo Therapeutics (AVTX) P/E from Jun 30, 2023 to Jul 21, 2026. The TTM Avalo Therapeutics (AVTX) P/E is -25.39. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Avalo Therapeutics (AVTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -25.39 | +3.63% |
| 2025 | -24.50 | -884.77% |
| 2024 | 3.12 | -120.02% |
| 2023 | -15.60 | N/A |
Comparison Avalo Therapeutics (AVTX) P/E with competitors
Avalo Therapeutics (AVTX) P/E is -25.39.